Lower Rates of  Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis.

Bryce, Aliya; Davison, Sara; Currie, Bart; Birrell, Johanna; Baird, Robert; Abeyaratne, Asanga; Majoni, Sandawana William; Brewster-O'Brien, Teana; Tong, Steven Y C

Title

Lower Rates of Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis.

Link to article in PubMed

https://pubmed.ncbi.nlm.nih.gov/39130084/?otool=iaurydwlib

Author(s)

Bryce, Aliya

Majoni, Sandawana William

Brewster-O'Brien, Teana

Tong, Steven Y C

Abstract

Hemodialysis is a risk factor for bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required.

Publication information

Open Forum Infect Dis . 2024 Jul 31;11(8):ofae431. doi: 10.1093/ofid/ofae431. eCollection 2024 Aug.

Date Issued

2024-07-31